Phase ⅡTrial of S1 Capsule Plus Cisplatin Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment in Stage Ⅱ-ⅢA Non-small Cell Lung Cancer (NSCLC) After Complete Resection

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02223611

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:35:38.574110+00:00

Published At

2014-08-22T00:00:00+00:00

Record Updated At

2014-08-22

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Non-small Cell Lung Cancer Stage \u2161", "Non-small Cell Lung Cancer Stage \u2162A"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2014-08-22"

protocolSection.identificationModule.nctId

"NCT02223611"

protocolSection.identificationModule.officialTitle

"Phase \u2161Trial of S1 Capsule Plus Cisplatin Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment in Stage \u2161-\u2162A Non-small Cell Lung Cancer (NSCLC) After Complete Resection"

protocolSection.statusModule.overallStatus

"UNKNOWN"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Non-small Cell Lung Cancer Stage Ⅱ (protocolSection.conditionsModule.conditions)
• Non-small Cell Lung Cancer Stage ⅢA (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.